CPHI (China Pharma Holdings) Return on Sales by Gross Profit

Corporate emblem and logo of chinapharmaholdings.com (CPHI)

Geopolitical tensions between the US and China are limiting the global sales of China Pharma Holdings (CPHI), triggering a decline in profitability within the generics sector. The gross margin as a percentage of revenue on the GURU.Markets daily chart clearly confirms this trend, where the indicator reaches -57.00. Close cooperation with Chinese pharmacies and hospitals regarding the supply of affordable psychotropic drugs is stabilizing the situation.

CPHI - China Pharma Holdings, Inc. Gross Margin over the range 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company China Pharma Holdings, Inc. (CPHI)

- cash position and cash flow details:
Fundamental valuation:China Pharma Holdings (CPHI)
Manufactured products of chinapharmaholdings.com

The fundamental stability of China Pharma Holdings (CPHI) depends on management's ability to optimize direct production costs. The implementation of ESG standards and the greening of raw material supply chains directly impact the cost of goods sold, which is reflected in profit dynamics. By analyzing the estimated gross margin, an investor can see the portion of revenue remaining after deducting material costs, thereby assessing the efficiency of resource control and the risk of overpaying for the asset.